Open Access<p>Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study</p>
Author(s) -
Xiaodong Tang,
Jie Xu,
Xin Sun,
Kuisheng Liu,
Xiaowei Li,
Fanglin He,
Xinyu Liu,
Jin Gu,
Zhe Lv,
Rongli Yang,
Xiaodong Tang,
Taiqiang Yan,
Dasen Li,
Yi Yang,
Song Dong,
Kunkun Sun,
Danhua Shen,
Wei Guo
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s253201
Subject(s) - apatinib , chondrosarcoma , medicine , sarcoma , univariate analysis , single center , mesenchymal chondrosarcoma , oncology , progression free survival , overall survival , radiology , pathology , multivariate analysis
For patients who have chondrosarcoma in the unresectable setting, antiangiogenic agents are reportedly effective. This multicenter, retrospective study investigated the antitumor activity of apatinib in patients with unresectable chondrosarcoma to gain insight into the biological behavior of this disease.